HIGHLIGHTS from SABCS: Assessing immune biomarkers of response to anthracyclines in breast cancer

Regarder maintenant HIGHLIGHTS from SABCS: Assessing immune biomarkers of response to anthracyclines in breast cancer

HIGHLIGHTS from SABCS: The Genomic Landscape of Male Breast Cancers using the Oncomine Comprehensive Assay for Actionable Mutations.

Regarder maintenant HIGHLIGHTS from SABCS: The Genomic Landscape of Male Breast Cancers using the Oncomine Comprehensive Assay for Actionable Mutations.

KEYNOTE-119: Phase 3 study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple-negative breast cancer (mTNBC).

Regarder maintenant KEYNOTE-119: Phase 3 study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple-negative breast cancer (mTNBC).

What’s needed next to meet the challenges in ER+ve breast cancer care?

Regarder maintenant What’s needed next to meet the challenges in ER+ve breast cancer care?

Strategies to consider to improve the slow progress in ER+ve BC and the risk of relapse

Regarder maintenant Strategies to consider to improve the slow progress in ER+ve BC and the risk of relapse